Biomarin Pharma
VIMIZIM
Manufacturer:
Biomarin Pharma
Name:
VIMIZIM
HCPCS Code Descriptor:
Injection, elosulfase alfa, 1 mg
Category:
J Code
HCPCS:
J1322
NDC(s):
68135-0100-01
Primary Type:
Enzyme Replacement Therapy
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
VIMIZIM is an Enzyme Replacement Therapy drug manufactured by Biomarin Pharma and administered via the Intravenous route of administration. The J Code: J1322 is aligned to the drug VIMIZIM.